{
    "organizations": [],
    "uuid": "476093dd176552349b03dc3b3caee3cbb80f6d71",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guerbet-partners-with-lausannes-ch/brief-guerbet-partners-with-lausannes-chuv-and-cet-to-launch-clinical-study-idUSL8N1RQ1AE",
    "ord_in_thread": 0,
    "title": "BRIEF-Guerbet Partners With Lausanne’S CHUV And CET To Launch Clinical Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 13 (Reuters) - Guerbet SA:\n* PARTNERS WITH LAUSANNE’S CHUV AND CET TO LAUNCH A CLINICAL STUDY\n* PARTNERS TO WORK TO CLARIFY IMMUNOMODULATORY AND ACTIVATING MECHANISMS INDUCED BY A CTACE PROCEDURE IN 20 PATIENTS WITH HCC Source text: bit.ly/2GVhPKT Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-13T15:26:00.000+03:00",
    "crawled": "2018-04-14T13:16:22.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "guerbet",
        "sa",
        "partner",
        "lausanne",
        "chuv",
        "cet",
        "launch",
        "clinical",
        "study",
        "partner",
        "work",
        "clarify",
        "immunomodulatory",
        "activating",
        "mechanism",
        "induced",
        "ctace",
        "procedure",
        "patient",
        "hcc",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}